L M Gallagher1, L J Owen, B G Keevil. 1. Department of Clinical Biochemistry, South Manchester University Hospitals NHS Trust, Manchester M23 9LT, UK.
Abstract
BACKGROUND: We aimed to develop a sensitive assay to quantitate serum concentrations of both androstenedione and testosterone within the female range simultaneously, using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for use in the routine clinical laboratory and to compare this method with immunoassay. METHOD: Samples (200 microL) were prepared by liquid-liquid extraction using (1 mL) methyl-tert-butyl-ether. Deuterated androstenedione and testosterone were used as internal standards. RESULTS: The standard curve was linear to 50 nmol/L, the lower limit of quantitation was 0.25 nmol/L, and intra- and inter-assay coefficients of variation were < 10% for both androgens over the range 0.3-35 nmol/L. There was a poor relationship between the LC-MS/MS and the radioimmunoassay methods for androstenedione with the LC-MS/MS generally giving lower results. For testosterone, the LC-MS/MS and immunoassay methods compared well at all concentrations. However, when female samples only were examined, the agreement deteriorated. CONCLUSIONS: We have developed a sensitive and precise LC-MS/MS method, which gives more accurate results for all androstenedione measurements and low testosterone concentrations than immunoassay.
BACKGROUND: We aimed to develop a sensitive assay to quantitate serum concentrations of both androstenedione and testosterone within the female range simultaneously, using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for use in the routine clinical laboratory and to compare this method with immunoassay. METHOD: Samples (200 microL) were prepared by liquid-liquid extraction using (1 mL) methyl-tert-butyl-ether. Deuterated androstenedione and testosterone were used as internal standards. RESULTS: The standard curve was linear to 50 nmol/L, the lower limit of quantitation was 0.25 nmol/L, and intra- and inter-assay coefficients of variation were < 10% for both androgens over the range 0.3-35 nmol/L. There was a poor relationship between the LC-MS/MS and the radioimmunoassay methods for androstenedione with the LC-MS/MS generally giving lower results. For testosterone, the LC-MS/MS and immunoassay methods compared well at all concentrations. However, when female samples only were examined, the agreement deteriorated. CONCLUSIONS: We have developed a sensitive and precise LC-MS/MS method, which gives more accurate results for all androstenedione measurements and low testosterone concentrations than immunoassay.
Authors: David Bann; Frederick C W Wu; Brian Keevil; Hany Lashen; Judith Adams; Rebecca Hardy; Graciela Muniz; Diana Kuh; Yoav Ben-Shlomo; Ken K Ong Journal: Obesity (Silver Spring) Date: 2015-06-05 Impact factor: 5.002
Authors: Li-Wei Cho; Thozhukat Sathyapalan; Eric S Kilpatrick; Brian G Keevil; Adrian G Miller; Anne M Coady; Lina Ahmed; Stephen L Atkin Journal: BMC Endocr Disord Date: 2017-05-19 Impact factor: 2.763
Authors: Thozhukat Sathyapalan; Ahmed Al-Qaissi; Eric S Kilpatrick; Soha R Dargham; Joanne Adaway; Brian Keevil; Stephen L Atkin Journal: Sci Rep Date: 2017-06-15 Impact factor: 4.379
Authors: David Bann; Rebecca Hardy; Rachel Cooper; Hany Lashen; Brian Keevil; Frederick C W Wu; Jeff M P Holly; Ken K Ong; Yoav Ben-Shlomo; Diana Kuh Journal: Soc Sci Med Date: 2015-11-06 Impact factor: 4.634